Head to head for first-timers
CoreAge Rx vs Belle Health
CoreAge Rx and Belle Health both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxBelle Health
Rank #27 for first-timers · Grade C
Mama-Match
Best for: Moms who want flat pricing plus dietitian support and are comfortable weighing an established operator against an open (not closed-out) FDA finding.
Visit Belle HealthThe verdict for a first step
CoreAge Rx edges out Belle Health on the Mama-Match Score, 94 to 67 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Belle Health is still a genuine option — flat-rate pricing with a real dietitian included ($119/mo semaglutide, from $175/mo tirzepatide) from a nine-year-old operator — carrying an open FDA warning letter over how it described its own compounded products. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Belle Health |
|---|---|---|
| Mama-Match Score | 94/100 · A | 67/100 · C |
| Overall rank | #1 | #27 |
| Semaglutide | $99/mo | $119/mo flat, all doses |
| Tirzepatide | $149/mo | From $175/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
Belle Health
Rank #27 · Grade C
What we like
- Flat-rate pricing — cost doesn't rise as your provider increases your dose
- Weekly registered-dietitian check-ins included at no extra cost
- Operating since 2017 with over 50,000 patients claimed; names five compounding pharmacy partners in its Terms
The caveats
- FDA Warning Letter 721795 (Feb 2026) found its marketing suggested Belle manufactured its own compounded products — misbranding under FDCA 502(a)/502(bb); no closeout letter published as of this check
- No brand-name (FDA-approved) option and no oral form
- Tirzepatide's exact current price is ambiguous between the homepage's 'from $175/mo' and an earlier-recorded $199/mo 3-month-bundle figure — confirm the live tier at signup
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Belle Health with the other providers we review for women.
Or browse the full comparison hub.